Phase 1 clinical trials focus on determining which of the following?

Phase 1 clinical trials focus on determining which of the following?

• A. Specific disease treatments
• B. Maximum tolerated dose and dose-limiting toxicities
• C. Cure rates of a new drug
• D. Quality of life indicators

Answer: (B)

Phase 1 clinical trials are primarily designed to assess the safety profile of a new drug or treatment. The focus is on determining the maximum tolerated dose (MTD), which is the highest dose that does not cause unacceptable side effects. Researchers closely monitor participants for dose-limiting toxicities (DLTs), which are the adverse effects that prevent increasing the dose further. The rationale behind this approach is to establish a safe dosage range before more extensive evaluations of efficacy are conducted in later-phase trials. While other phases of clinical trials investigate specific disease treatments, cure rates, and quality of life indicators, the initial phase is crucial for understanding how much of a drug patients can tolerate and what potential side effects may arise. This foundational knowledge is essential before moving on to later studies that might involve clinical efficacy in treating specific diseases or assessing improvement in quality of life.

Phase 1 clinical trials are primarily designed to assess the safety profile of a new drug or treatment. The focus is on determining the maximum tolerated dose (MTD), which is the highest dose that does not cause unacceptable side effects. Researchers closely monitor participants for dose-limiting toxicities (DLTs), which are the adverse effects that prevent increasing the dose further.

The rationale behind this approach is to establish a safe dosage range before more extensive evaluations of efficacy are conducted in later-phase trials. While other phases of clinical trials investigate specific disease treatments, cure rates, and quality of life indicators, the initial phase is crucial for understanding how much of a drug patients can tolerate and what potential side effects may arise. This foundational knowledge is essential before moving on to later studies that might involve clinical efficacy in treating specific diseases or assessing improvement in quality of life.